UpTick Newswire Radio Show Will Interview BioElectronics' CEO Andrew Whelan
Topics Will Include UK Market Expansion and US FDA Status
(firmenpresse) - FREDERICK, MD -- (Marketwired) -- 11/04/15 -- BioElectronics Corporation (OTC PINK: BIEL), maker of consumer medical electronics products for pain management, announced that Andrew J. Whelan, President, will be interviewed by Stu Taylor on his program "On Business" at 9am EST on Thursday, November 5th. To listen to the interview live, tune to:
Mr. Whelan is expected to report on the exceptional acceptance the company's flagship product, ActiPatch Pain Relief Therapy, is achieving in the UK. Other topics for discussion include the US FDA market clearance application and Canada distribution progress.
BioElectronics Corporation is a leader in biophysics and the maker of an industry leading family of disposable, drug-free, pain therapy devices: ActiPatch® Therapy, over-the-counter treatment for back pain and other musculoskeletal complaints; RecoveryRx® Devices for chronic and post-operative wound care; Allay® Menstrual Pain Therapy; and HealFast® Therapy for dogs, cats and horses. For more information, please visit .
Stu Taylor's "On Business Program airs on Radio America Network & Biz Talk Radio Network Stu Taylor is the nationally syndicated business radio talk show host of Equity Strategies, and the host of Boston morning drive with Stu Taylor on Business.
BioElectronics
Paul Knopick
940.262.3584
Stu Taylor
Brittney Lewellen
Media Relations
Direct Line: 602-441-3474
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 04.11.2015 - 13:00 Uhr
Sprache: Deutsch
News-ID 431852
Anzahl Zeichen: 0
contact information:
Town:
FREDERICK, MD
Kategorie:
Personal Care & Fitness
Diese Pressemitteilung wurde bisher 162 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"UpTick Newswire Radio Show Will Interview BioElectronics' CEO Andrew Whelan"
steht unter der journalistisch-redaktionellen Verantwortung von
BioElectronics Corporation (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
